THNR
THNR
About Amplify Weight Loss Drug & Treatment ETF
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.
About Amplify Weight Loss Drug & Treatment ETF
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 LLY | Eli Lilly and Company | 12.37% | 519 | $545.98K |
 NVO | Novo Nordisk A/S | 8.92% | 10.51K | $393.71K |
 AMGN | Amgen Inc. | 7.80% | 887 | $344.30K |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.66% | 376 | $293.91K |
 MRK | Merck & Co., Inc. | 5.98% | 2.13K | $263.98K |
 AZN | AstraZeneca PLC | 5.52% | 1.17K | $243.47K |
 PFE | Pfizer Inc. | 5.14% | 8.20K | $226.70K |
 ABBV | AbbVie Inc. | 4.94% | 940 | $218.16K |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 3.68% | 2.57K | $162.54K |
 VKTX | Viking Therapeutics, Inc. | 1.71% | 2.24K | $75.67K |
 SRRK | Scholar Rock Holding Corporation | 1.62% | 1.61K | $71.50K |
 HIMS | Hims & Hers Health, Inc. | 1.37% | 4.17K | $60.53K |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
United States
Japan
Denmark
China
Switzerland
United Kingdom
South KoreaSECTOR HOLDINGS
Healthcare Financial Services Cash & OthersASSET ALLOCATION BY REGION
United States Japan Denmark China Switzerland United Kingdom South KoreaHoldings (Top 20)
LLY
Eli Lilly and Company
NVO
Novo Nordisk A/S
AMGN
Amgen Inc.
REGN
Regeneron Pharmaceuticals, Inc.
MRK
Merck & Co., Inc.
AZN
AstraZeneca PLC
PFE
Pfizer Inc.
ABBV
AbbVie Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
VKTX
Viking Therapeutics, Inc.
SRRK
Scholar Rock Holding Corporation
HIMS
Hims & Hers Health, Inc.